Nearly all ATRX-mutated gliomas also harbor TP53 mutations and it was discovered that TP53 mutations occur first and predispose towards the acquisition of ATRX loss of function (Cryan et al., 2014). The gene discussed is ATRX; the disease is central nervous system cancer.